Discover

DH
Definitive Healthcare Corp.
0.98
2 x 0.70
1 x 0.99
bid
ask
+
0.01
0.52%
2 @ 04:00 PM
0.98 -0.00 (0.13%)
Ytd-65.80%
1y-67.18%
0.97
day range
0.99
0.61
52 week range
3.12
Open0.97Prev Close0.98Low0.97High0.99Mkt Cap104.76M
Vol186.31KAvg Vol588.72KEPS-1.61P/EN/AForward P/E13.42
Beta1.33Short Ratio4.71Inst. Own95.44%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0550-d Avg0.87200-d Avg1.181yr Est5.25

DH News

Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison
defenseworld.net
Definitive Healthcare (NASDAQ:DH) versus Firefly Neuroscience (NASDAQ:AIFF) Financial Comparison

Definitive Healthcare (NASDAQ: DH - Get Free Report) and Firefly Neuroscience (NASDAQ: AIFF - Get Fr

Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing
globenewswire.com
Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance

Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest stand

Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)
defenseworld.net
Financial Review: HealthStream (NASDAQ:HSTM) versus Definitive Healthcare (NASDAQ:DH)

HealthStream (NASDAQ: HSTM - Get Free Report) and Definitive Healthcare (NASDAQ: DH - Get Free Repor

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednes

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International
globenewswire.com
Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Adv

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”

benzinga.com
Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop

Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in he

Definitive Healthcare Appoints Clay Ritchey as CEO
globenewswire.com
Definitive Healthcare Appoints Clay Ritchey as CEO

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healt

Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison
defenseworld.net
Definitive Healthcare (NASDAQ:DH) & Certara (NASDAQ:CERT) Financial Comparison

Definitive Healthcare (NASDAQ: DH - Get Free Report) and Certara (NASDAQ: CERT - Get Free Report) ar

Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Reduce” by Analysts
defenseworld.net
Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Reduce” by Analysts

Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has received a consensus rating of "Reduc

benzinga.com
Morgan Stanley Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $1.5

Morgan Stanley analyst Craig Hettenbach maintains Definitive Healthcare (NASDAQ:DH) with a Equal-

Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript
seekingalpha.com
Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates
zacks.com
Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Za

Definitive Healthcare Q2 Earnings Call Highlights
marketbeat.com
Definitive Healthcare Q2 Earnings Call Highlights

Definitive Healthcare NASDAQ: DH reported second-quarter fiscal 2026 revenue and profitability that

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's af

benzinga.com
Definitive Healthcare Raises FY2026 Adj EPS Guidance from $0.16-$0.19 to $0.18-$0.20 vs $0.18 Est; N

Definitive Healthcare (NASDAQ:DH) raises FY2026 Adj EPS guidance from $0.16-$0.19 to $0.18-$0.20 vs

benzinga.com
Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.

Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.04-$0.05 vs $0.04 analyst estimate

benzinga.com
Definitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.05 per share which beat the anal

Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform
globenewswire.com
Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Plat

Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportu

Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast
globenewswire.com
Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call

FRAMINGHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Health

Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for
zacks.com
Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out

Definitive Healthcare (DH) doesn't possess the right combination of the two key ingredients for a li

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

FRAMINGHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry

benzinga.com
B of A Securities Downgrades Definitive Healthcare to Underperform, Lowers Price Target to $0.7

B of A Securities analyst Allen Lutz downgrades Definitive Healthcare (NASDAQ:DH) from Buy to Und

Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Success
prnewswire.com
Restaurant365 Names Kate Hastings Chief Customer Officer as It Expands Investment in Customer Succes

Customer success leader joins executive team to help restaurant operators accelerate value realizati

Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights
globenewswire.com
Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

FRAMINGHAM, Mass. , May 21, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a provider

Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript
seekingalpha.com
Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q1 2026 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates
zacks.com
Definitive Healthcare Corp. (DH) Tops Q1 Earnings Estimates

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.06 per share, beating the Za

Definitive Healthcare Reports Financial Results for First Quarter 2026
globenewswire.com
Definitive Healthcare Reports Financial Results for First Quarter 2026

FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthc

benzinga.com
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $1

Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and l

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1
benzinga.com
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q1

Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term p

benzinga.com
Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $3

Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and

benzinga.com
Stephens & Co. Maintains Equal-Weight on Definitive Healthcare, Lowers Price Target to $2

Stephens & Co. analyst Jeff Garro maintains Definitive Healthcare (NASDAQ:DH) with a Equal-We

Definitive Healthcare Q4 Earnings Report: What Investors Need to Know
benzinga.com
Definitive Healthcare Q4 Earnings Report: What Investors Need to Know

benzinga.com
Definitive Healthcare Sees FY2026 Adj EPS $0.14-$0.17 vs $0.26 Est; Sees Sales $220.000M-$226.000M v

Definitive Healthcare (NASDAQ:DH) is looking for FY2026 Adj EPS of $0.14-$0.17 vs $0.26 analyst esti

benzinga.com
Definitive Healthcare Sees Q1 Adj EPS $0.03 vs $0.06 Est; Sees Sales $54.000M-$56.000M vs $57.228M E

Definitive Healthcare (NASDAQ:DH) is looking for Q1 Adj EPS of $0.03 vs $0.06 analyst estimate. sees

benzinga.com
Definitive Healthcare Q4 Adj. EPS $0.06, Inline, Sales $61.534M Beat $59.569M Estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.06 per share which met the analy

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

benzinga.com
Barclays Maintains Underweight on Definitive Healthcare, Lowers Price Target to $2.75

Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and l

benzinga.com
Canaccord Genuity Maintains Hold on Definitive Healthcare, Lowers Price Target to $4

Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and

benzinga.com
Definitive Healthcare Raises FY2025 Adj EPS Guidance from $0.22-$0.23 to $0.23-$0.24 vs $0.23 Est; R

Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.22-$0.23 to $0.23-$0.24 vs

benzinga.com
Definitive Healthcare Sees Q4 Adj EPS $0.05-$0.06 vs $0.06 Est; Sees Sales $59.000M-$60.000M vs $59.

Definitive Healthcare (NASDAQ:DH) is looking for Q4 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate

benzinga.com
Definitive Healthcare Q3 Adj. EPS $0.07 Beats $0.06 Estimate, Sales $60.046M Beat $59.488M Estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the anal

Earnings Scheduled For November 6, 2025
benzinga.com
Earnings Scheduled For November 6, 2025

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga.com
Stifel Maintains Buy on Definitive Healthcare, Raises Price Target to $6

Stifel analyst David Grossman maintains Definitive Healthcare (NASDAQ:DH) with a Buy and raises t

benzinga.com
Definitive Healthcare Raises FY2025 Adj EPS Guidance from $0.20-$0.23 to $0.22-$0.23 vs $0.21 Est; R

Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.20-$0.23 to $0.22-$0.23 vs

benzinga.com
Definitive Healthcare Sees Q3 Adj EPS $0.05-$0.06 vs $0.06 Est; Sees Sales $59.000M-$60.000M vs $59.

Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate

benzinga.com
Definitive Healthcare Q2 Adj. EPS $0.07 Beats $0.05 Estimate, Sales $60.750M Beat $59.200M Estimate

Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the anal

benzinga.com
Earnings Scheduled For August 7, 2025

SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session